Siga Technologies Drug Patent Portfolio

Siga Technologies owns 1 orange book drug protected by 10 US patents Given below is the list of Siga Technologies's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11890270 Polymorphic forms of ST-246 and methods of preparation 08 Aug, 2032
Active
US7737168 Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases 04 Sep, 2031
Active
US10576165 ST-246 liquid formulations and methods 02 Aug, 2031
Active
US9233097 ST-246 liquid formulations 02 Aug, 2031
Active
US9907859 ST-246 liquid formulations and methods 02 Aug, 2031
Active
US9339466 Polymorphic forms of ST-246 and methods of preparation 23 Mar, 2031
Active
US8039504 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases 23 Jul, 2027
Active
US8124643 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases 18 Jun, 2024 Expired
US8530509 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases 18 Jun, 2024 Expired
US8802714 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases 18 Jun, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Siga Technologies.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 06 Feb, 2024 US11890270
Patent Issue Date Used in PTA Calculation 06 Feb, 2024 US11890270
Mail Patent eGrant Notification 06 Feb, 2024 US11890270
Patent eGrant Notification 06 Feb, 2024 US11890270
Recordation of Patent eGrant 06 Feb, 2024 US11890270
Email Notification 06 Feb, 2024 US11890270
Email Notification 18 Jan, 2024 US11890270
Issue Notification Mailed 17 Jan, 2024 US11890270
Dispatch to FDC 21 Dec, 2023 US11890270
Application Is Considered Ready for Issue 21 Dec, 2023 US11890270
Issue Fee Payment Received 19 Dec, 2023 US11890270
Issue Fee Payment Verified 19 Dec, 2023 US11890270
Payment of Maintenance Fee, 8th Yr, Small Entity 17 Nov, 2023 US9339466
Mail Notice of Allowance 29 Sep, 2023 US11890270
Notice of Allowance Data Verification Completed 26 Sep, 2023 US11890270


Siga Technologies's Family Patents

Siga Technologies drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 27.3% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Siga Technologies Drug List

Given below is the complete list of Siga Technologies's drugs and the patents protecting them.


1. Tpoxx

Tpoxx is protected by 10 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11890270 Polymorphic forms of ST-246 and methods of preparation 08 Aug, 2032
(7 years from now)
Active
US7737168 Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases 04 Sep, 2031
(6 years from now)
Active
US10576165 ST-246 liquid formulations and methods 02 Aug, 2031
(6 years from now)
Active
US9233097 ST-246 liquid formulations 02 Aug, 2031
(6 years from now)
Active
US9907859 ST-246 liquid formulations and methods 02 Aug, 2031
(6 years from now)
Active
US9339466 Polymorphic forms of ST-246 and methods of preparation 23 Mar, 2031
(6 years from now)
Active
US8039504 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases 23 Jul, 2027
(2 years from now)
Active
US8124643 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases 18 Jun, 2024
(3 months ago)
Expired
US8530509 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases 18 Jun, 2024
(3 months ago)
Expired
US8802714 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases 18 Jun, 2024
(3 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tpoxx's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List